KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Total Non-Current Liabilities (2016 - 2025)

Jazz Pharmaceuticals has reported Total Non-Current Liabilities over the past 15 years, most recently at $7.2 billion for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 7.86% to $7.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.2 billion through Dec 2025, down 7.86% year-over-year, with the annual reading at $7.2 billion for FY2025, 7.86% down from the prior year.
  • Total Non-Current Liabilities was $7.2 billion for Q4 2025 at Jazz Pharmaceuticals, down from $7.3 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $8.9 billion in Q2 2021 and troughed at $2.9 billion in Q1 2021.
  • The 5-year median for Total Non-Current Liabilities is $7.6 billion (2023), against an average of $7.5 billion.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 220.77% in 2021 and later dropped 12.06% in 2022.
  • Tracing JAZZ's Total Non-Current Liabilities over 5 years: stood at $8.2 billion in 2021, then dropped by 7.2% to $7.6 billion in 2022, then dropped by 0.95% to $7.5 billion in 2023, then increased by 3.96% to $7.8 billion in 2024, then decreased by 7.86% to $7.2 billion in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $7.2 billion, $7.3 billion, and $7.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.